Search Results - "Radomski, M.W"

Refine Results
  1. 1
  2. 2

    Nitric oxide synthase activities in human myocardium by de Belder, A J, Radomski, M W, Why, H J, Richardson, P J, Bucknall, C A, Salas, E, Martin, J F, Moncada, S

    Published in The Lancet (British edition) (09-01-1993)
    “…Myocardial constitutive and inducible nitric oxide (NO) synthase activities were measured in right ventricular tissue from 17 patients with dilated…”
    Get more information
    Journal Article
  3. 3

    The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide by Radomski, M.W., Palmer, R.M.J., Moncada, S.

    Published in British journal of pharmacology (01-11-1987)
    “…1 The interactions between endothelium‐derived nitric oxide (NO) and prostacyclin as inhibitors of platelet aggregation were examined. 2 Porcine aortic…”
    Get full text
    Journal Article
  4. 4

    Comparative pharmacology of endothelium‐derived relaxing factor, nitric oxide and prostacyclin in platelets by Radomski, M.W., Palmer, R.M.J., Moncada, S.

    Published in British journal of pharmacology (01-09-1987)
    “…1 The pharmacological effects of endothelium‐derived relaxing factor (EDRF), nitric oxide (NO) and prostacyclin on human and rabbit platelets were examined. 2…”
    Get full text
    Journal Article
  5. 5

    Characterization of the l‐arginine: nitric oxide pathway in human platelets by Radomski, M.W., Palmer, R.M.J., Moncada, S.

    Published in British journal of pharmacology (01-10-1990)
    “…1 The activation of the l‐arginine:nitric oxide (NO) pathway during aggregation of human platelets by adenosine 5′‐diphosphate (ADP), arachidonic acid,…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Generation of platelet angiostatin mediated by urokinase plasminogen activator: effects on angiogenesis by JURASZ, P., SANTOS‐MARTINEZ, M. J., RADOMSKA, A., RADOMSKI, M. W.

    Published in Journal of thrombosis and haemostasis (01-05-2006)
    “…Background: Angiogenesis, the growth of new capillaries from pre‐existing blood vessels, is regulated by a balance between its promoters and inhibitors…”
    Get full text
    Journal Article
  8. 8
  9. 9

    CYCLIC GMP MEDIATES THE INHIBITORY EFFECT OF NITRIC OXIDE ON PLATELET ADHESION by Radomski, M.W., Martinez-Cuesta, M.A.

    Published in Japanese Journal of Pharmacology (1997)
    “…Platelet adhesion is one of the initial events involved in haemostasis and thrombosis. Nitric oxide inhibits platelet adhesion, however the contribution of…”
    Get full text
    Journal Article
  10. 10

    The duality of sleeping sickness: focusing on sleep by Buguet, A, Bourdon, L, Bouteille, B, Cespuglio, R, Vincendeau, P, Radomski, M.W, Dumas, M

    Published in Sleep medicine reviews (01-04-2001)
    “…Sleeping sickness, once under control, is a re-emergent endemic parasitic disease in intertropical Africa. Its originality resides in its duality. Two…”
    Get full text
    Journal Article
  11. 11

    Direct electrochemical measurement of nitric oxide released from human platelets by Malinski, T, Radomski, M W, Taha, Z, Moncada, S

    “…A porphyrinic microsensor has been used to investigate the release of nitric oxide (NO) from human platelets in whole blood and in washed platelet suspensions…”
    Get more information
    Journal Article
  12. 12

    Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty by Langford, E J, Brown, A S, Wainwright, R J, de Belder, A J, Thomas, M R, Smith, R E, Radomski, M W, Martin, J F, Moncada, S

    Published in The Lancet (British edition) (26-11-1994)
    “…Platelet activation is associated with acute vessel occlusion and chronic restenosis after percutaneous transluminal coronary angioplasty (PTCA). Organic…”
    Get more information
    Journal Article
  13. 13

    MYOCARDIAL NOS ACTIVITY IS INCREASED FOLLOWING CANINE CARDIOPULMONARY BYPASS by Mayers, I., Johnson, D., Salas, E., Hurst, T., Radomski, M.W.

    Published in Japanese Journal of Pharmacology (1997)
    “…Cytokines are known to contribute to a specific cardiac dysfunction caused by cardiopulmonary bypass (CPB). Since inducible NO mediates some of cytokine…”
    Get full text
    Journal Article
  14. 14

    METABOLISM OF L-ARGININE IN END STAGE LIVER DISEASE IN HUMANS by Radomski, M.W., McNaughton, L., Martinez-Cuesta, M.A., Kneteman, N., Mayers, I.

    Published in Japanese Journal of Pharmacology (1997)
    “…Arginase and NOS have been identified as arginine-metabolizing enzymes in liver. We have investigated the relative activities of enzymes in patients undergoing…”
    Get full text
    Journal Article
  15. 15

    Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium by Radomski, M W, Palmer, R M, Moncada, S

    Published in The Lancet (British edition) (07-11-1987)
    “…The adhesion of human platelets to monolayers of bovine endothelial cells in culture was studied to determine the role of endothelium-derived nitric oxide in…”
    Get more information
    Journal Article
  16. 16

    Inhaled nitric oxide inhibits the release of matrix metalloproteinase-2, but not platelet activation, during extracorporeal membrane oxygenation in adult rabbits by Cheung, P.-Y., Sawicki, G., Peliowski, A., Etches, P.C., Schulz, R., Radomski, M.W.

    Published in Journal of pediatric surgery (01-04-2003)
    “…In neonates receiving extracorporeal membrane oxygenation (ECMO), platelet activation and dysfunction occur with the release of matrix metalloproteinase…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Comparative pharmacology of analogues of S‐nitroso‐N‐acetyl‐dl‐penicillamine on human platelets by Salas, E., Moro, M.A., Askew, S., Hodson, H.F., Butler, A.R., Radomski, M.W., Moncada, S.

    Published in British journal of pharmacology (01-08-1994)
    “…1 The effects of two new analogues of S‐nitroso‐N‐acetyl‐dl‐penicillamine (SNAP), S‐nitroso‐N‐formyl‐dl‐penicillamine (SNFP) and S‐nitroso‐dl‐penicillamine…”
    Get full text
    Journal Article
  19. 19
  20. 20